NYSE:CLVT Clarivate (CLVT) Stock Price, News & Analysis $5.09 +0.22 (+4.52%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Clarivate Stock (NYSE:CLVT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Clarivate alerts:Sign Up Key Stats Today's Range$4.86▼$5.2250-Day Range$4.33▼$7.1052-Week Range$4.25▼$9.60Volume8.94 million shsAverage Volume4.49 million shsMarket Capitalization$3.62 billionP/E RatioN/ADividend YieldN/APrice Target$7.25Consensus RatingHold Company OverviewClarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.Read More… [Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Clarivate Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks48th Percentile Overall ScoreCLVT MarketRank™: Clarivate scored higher than 48% of companies evaluated by MarketBeat, and ranked 427th out of 648 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingClarivate has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 3 hold ratings, and 2 sell ratings.Amount of Analyst CoverageClarivate has only been the subject of 3 research reports in the past 90 days.Read more about Clarivate's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-1.59% Earnings GrowthEarnings for Clarivate are expected to decrease by -1.59% in the coming year, from $0.63 to $0.62 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clarivate is -2.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clarivate is -2.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClarivate has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Clarivate's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.40% of the float of Clarivate has been sold short.Short Interest Ratio / Days to CoverClarivate has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in Clarivate has recently increased by 9.55%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldClarivate does not currently pay a dividend.Dividend GrowthClarivate does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.40% of the float of Clarivate has been sold short.Short Interest Ratio / Days to CoverClarivate has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in Clarivate has recently increased by 9.55%, indicating that investor sentiment is decreasing significantly. News and Social Media2.5 / 5News Sentiment0.41 News SentimentClarivate has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Clarivate this week, compared to 5 articles on an average week.Search Interest5 people have searched for CLVT on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Clarivate to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Clarivate insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,379,110.00 in company stock.Percentage Held by Insiders23.14% of the stock of Clarivate is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions85.72% of the stock of Clarivate is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Clarivate's insider trading history. Receive CLVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clarivate and its competitors with MarketBeat's FREE daily newsletter. Email Address CLVT Stock News HeadlinesBioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special SeriesNovember 21 at 3:00 AM | prnewswire.comClarivate Plc: Clarivate Reveals Highly Cited Researchers 2024 ListNovember 19 at 4:59 AM | finanznachrichten.de[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.November 21, 2024 | Paradigm Press (Ad)Clarivate Reveals Highly Cited Researchers 2024 ListNovember 19 at 3:00 AM | prnewswire.comClarivate Plc: New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global InfluenceNovember 18 at 6:51 AM | finanznachrichten.deNew Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global InfluenceNovember 18 at 3:00 AM | prnewswire.comClarivate (NYSE:CLVT) Hits New 52-Week Low - Time to Sell?November 17, 2024 | americanbankingnews.comClarivate Plc: Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award WinnersNovember 13, 2024 | finanznachrichten.deSee More Headlines CLVT Stock Analysis - Frequently Asked Questions How have CLVT shares performed this year? Clarivate's stock was trading at $9.26 at the start of the year. Since then, CLVT shares have decreased by 45.0% and is now trading at $5.09. View the best growth stocks for 2024 here. How were Clarivate's earnings last quarter? Clarivate Plc (NYSE:CLVT) released its quarterly earnings results on Wednesday, November, 6th. The company reported $0.19 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.19. The company's revenue for the quarter was down 3.9% on a year-over-year basis. Who are Clarivate's major shareholders? Top institutional investors of Clarivate include Clarkston Capital Partners LLC (9.03%), Janus Henderson Group PLC (1.77%), Thompson Siegel & Walmsley LLC (1.29%) and Perpetual Ltd (1.10%). Insiders that own company stock include Bar Veinstein, James Gordon Samson, Andrew Miles Snyder, Saurabh Saha and Mukhtar Ahmed. View institutional ownership trends. How do I buy shares of Clarivate? Shares of CLVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Clarivate own? Based on aggregate information from My MarketBeat watchlists, some other companies that Clarivate investors own include Cisco Systems (CSCO), Home Depot (HD), Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD) and Walmart (WMT). Company Calendar Last Earnings11/06/2024Today11/20/2024Fiscal Year End12/31/2024Next Earnings (Estimated)2/25/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Data processing & preparation Sub-IndustryBusiness Services Current SymbolNYSE:CLVT CUSIPN/A CIK1764046 Webwww.clarivate.com Phone442074334000FaxN/AEmployees12,000Year FoundedN/APrice Target and Rating Average Stock Price Target$7.25 High Stock Price Target$10.00 Low Stock Price Target$4.00 Potential Upside/Downside+42.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($1.99) Trailing P/E RatioN/A Forward P/E Ratio8.08 P/E GrowthN/ANet Income$-911,200,000.00 Net Margins-50.00% Pretax Margin-49.80% Return on Equity9.69% Return on Assets3.97% Debt Debt-to-Equity Ratio0.84 Current Ratio0.88 Quick Ratio0.88 Sales & Book Value Annual Sales$2.58 billion Price / Sales1.40 Cash Flow$2.14 per share Price / Cash Flow2.38 Book Value$6.93 per share Price / Book0.73Miscellaneous Outstanding Shares710,404,000Free Float546,017,000Market Cap$3.62 billion OptionableOptionable Beta1.18 Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (NYSE:CLVT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarivate Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Clarivate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.